Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges

Post time 2022-12-3 20:55:24

journal：Current Pharmaceutical Design

Authors：Elena S. López; Ana L.L. Machado; Lorena B. Vidal; Roberto González-Pizarro; Amelia D. Silva; Eliana B. Souto

Published date：2020-5-6

DOI：10.2174/1381612826666200218101231

Article link：http://dx.doi.org/10.2174/1381612826666200218101231

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 2022-12-3 20:55:25

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges